Document Detail

Anaerobic bacteria as a cause of mycotic aneurysm of the aorta: microbiology and antimicrobial therapy.
Jump to Full Text
MedLine Citation:
PMID:  20066146     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
This review summarizes the microbiology, and antimicrobial management of mycotic aneurysm of the aorta (MAA) due to anaerobic bacteria. Anaerobic bacteria are an uncommon but important cause of MAA. Most cases of anaerobic MAA are caused anaerobic gram-negative bacilli (mostly B. fragilis group), Clostridium spp. (mostly Clostridium septicum, and Propionobacterium spp. (mostly P. acnes). Clostridial infection is frequently associated with gastrointestinal or hematologic malignancy. A review of all the reported cases is presented. Treatment of MAA involving anaerobic bacteria includes the use of antimicrobial effective against these organisms.
Authors:
Itzhak Brook
Related Documents :
10585076 - Common arterial trunk associated with double aortic arch.
21318136 - Spontaneous hemopericardium leading to cardiac tamponade in a patient with essential th...
17448766 - Coming face to face with the stenotic mace-combined maceoscopy and colonoscopy (the ren...
19545496 - Diagnosis and management of mycotic aneurysms.
11414126 - The danish multiple sclerosis registry. history, data collection and validity.
2682216 - A case of post-traumatic tic disorder.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reviews     Volume:  5     ISSN:  1875-6557     ISO Abbreviation:  Curr Cardiol Rev     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2010-01-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101261935     Medline TA:  Curr Cardiol Rev     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  36-9     Citation Subset:  -    
Affiliation:
Departments of Pediatrics and Medicine, Georgetown University School of Medicine, Washington DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Curr Cardiol Rev
Journal ID (publisher-id): CCR
ISSN: 1573-403X
ISSN: 1875-6557
Publisher: Bentham Science Publishers Ltd
Article Information
Download PDF
© 2009 Bentham Science Publishers Ltd.
open-access:
Received Day: 1 Month: 5 Year: 2008
Revision Received Day: 26 Month: 7 Year: 2008
Accepted Day: 26 Month: 7 Year: 2008
Print publication date: Month: 1 Year: 2009
Volume: 5 Issue: 1
First Page: 36 Last Page: 39
ID: 2803286
PubMed Id: 20066146
Publisher Id: CCR-5-36
DOI: 10.2174/157340309787048095

Anaerobic Bacteria as a Cause of Mycotic Aneurysm of the Aorta: Microbiology and Antimicrobial Therapy
Itzhak Brook*
Departments of Pediatrics and Medicine, Georgetown University School of Medicine, Washington DC, USA
*Address for correspondence to this author at the Departments of Pediatrics and Medicine, Georgetown University School of Medicine, 4431 Albemarle st NW, Washington DC 20016, USA; Tel: (202) 363-4253; Fax: (202) 244-6809; E-mail: ib6@georgetown.edu

INTRODUCTION

Infections due to anaerobic bacteria are common, and can be serious and life-threatening. The recent increased in the recovery of these organisms in all infectious sites [1] including bacteremia [2] has led to greater appreciation of the role anaerobes play in infections at all body sites, including mycotic aneurysm of the aorta (MAA).

As the main components of the normal human skin and mucous membranes bacterial flora, anaerobes are a common cause of endogenous bacterial infections. Because of their fastidiousness, they are difficult to isolate from infected sites, and are often overlooked. Their exact frequency is hard to ascertain because of the inconsistent utilization of adequate methods for their isolation and identification. The lack of directing adequate antimicrobial therapy against these organisms may lead to clinical failures, complication and increase mortality. Their isolation requires appropriate methods of collection transportation and cultivation of specimens. Treatment of anaerobic infection is complicated by their polymicrobial nature, and by the slow growth and growing resistance to antimicrobials of anaerobic bacteria [3].

MAA is a life-threatening condition with significant morbidity and mortality. Staphylococcus and Salmonella spp. are the two most commonly cultured organisms in mycotic aneurysms. However, improved bacteriologic techniques have led to the detection of anaerobic bacteria (mostly Bacteroides, and Clostridium spp.) in MAA [4]. This review describes the microbiology and antimicrobial management of MAA due to anaerobic bacteria.


MICROBIOLOGY

The study by Brook and Frazier [4] illustrated the diversity of anaerobic bacteria recovered from patients with MAA. The study was conducted between 1987 and 1992 and presented 8 cases with MAA who had aerobic and anaerobic cultures. Eleven organisms, 6 aerobic and facultative and 5 anaerobic, were isolated. Aerobic organisms only were isolated in 4 cases, anaerobic organisms only in 3, and mixed aerobic and anaerobic bacteria in one. Polymicrobial infection was present in three. The isolated aerobic bacteria were Staphylococcus aureus (2 isolates), and Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, and Salmonella enteritidis (one each). The recovered anaerobes were Peptostreptococcus spp. (2), and Bacteroides fragilis, Propionibacterium acnes, and Clostridium perfingens (one each). Organisms similar to the one recovered from the MAA were isolated from the blood of 4 patients. These include one isolate each of S. aureus, E. coli, B. fragilis, and C. perfringens.

Several case reports of MAA due to anaerobic bacteria (mainly B. fragilis and Clostridium septicum) were published.

Bacteroides fragilis Infections

Sheehan [5] presented a patient with aortitis due to Bacteroides spp. that developed MAA, which ruptured following translumbar aortography. Reddy et al. [6] reported a patient with a 7 cm saccular MAA due to B. fragilis that emerged in the suprarenal abdominal area.

Suddleson et al. [7] presented a case of mycotic suprarenal MAA caused by B. fragilis. The patient was treated only with continuous antibiotic therapy and had a complete recovery. Taylor et al. [8] described a patient with infected abdominal aortoiliac mycotic aneurysm caused by Bacteroides spp. The patient was treated with appropriate antibiotics and a single operative procedure consisting of preliminary extraanatomic bypass followed by complete aneurysm excision and posterior drainage of the retroperitoneum. Jewkes and Black [9] reported a case with MAA caused by a Gram-negative anaerobic organism. The MAA was in the abdominal area and was a consequence of an abscess of the appendix.

Reddy et al. [10] performed a 30-year retrospective review and identified 13 patients treated for infected aneurysms of the abdominal aorta or iliac arteries. Four (31%) of the patients died within 30 days of operation, three of whom of aneurysmal rupture. Salmonella spp., B. fragilis, S. aureus and Pseudomonas aeruginosa accounted for all deaths, ruptures, and suprarenal aneurysm infections which occurred in 10 (77%) of the patients.

Hsu et al. [11] performed a retrospective review of all 19 patients with MAA treated at a single center over 5 years. The most common pathogens were Salmonella spp. (74%) and Streptococcus spp. (11%). There was a single case of B. fragilis who did not survive.

Matsuyama et al. [12] successfully-treated a patient with acute MAA due to B. fragilis by placing a dacron graft replacement between the distal arch and the proximal descending aorta with teflon felt reinforcement, and covering the graft with omental flap.

Tsuji et al. [13] successfully treated a patient with a mycotic aneurysm caused by B. fragilis of the common iliac artery complicated with vertebral spondylitis. Under midline laparotomy, complete debridement of the infected tissues, in-situ replacement of the common iliac artery with cryopreserved aortic allograft, and iliac bone autotransplantation and omentopexy to fill the debrided cavity were performed.

Beland et al. [14] described a patient suffering from leprosy that developed B. fragilis sepsis and MAA.

Clostridium septicum Infections

Takano et al. [15] reported a case of mycotic aneurysm of the infrarenal abdominal aorta infected by C. septicum and reviewed 18 addition cases. Of the total of 19 cases of aneurysm caused by C. septicum that have been reported, [16-33] at the time of the review the aneurysm was located in the abdominal aorta in 6, the thoracic in 4, the thoracoabdominal in 2, the iliac artery in 2, the popliteal artery in 1, and the thoracic aorta and abdominal aorta (double aneurysm) in 1 patient. In addition, two cases of aortic dissection caused by C. septicum infection have been reported [32, 33]. In these 19 cases, there were 14 with colon neoplasm, 11 of which were colon cancer. Ten of the 12 patients who underwent vascular surgery survived, whereas all 7 who did not undergo surgery died, mostly from aneurysmal rupture. Thus, surgical treatment seems to be needed to achieve optimal results.

A typical finding of clostridial mycotic aneurysms in the CT scan is gas formation surrounding the aorta or peripheral arteries [15]. Clostridia can proliferate in tissues when oxidation-reduction falls or the pH is reduced, which may occur with arterial injury, necrotic tissue, or anoxic tissue with lactic acid accumulation. For this reason, clostridial infection is frequently associated with gastrointestinal or hematologic malignancy. Kornbluth et al. [34] reported an associated malignancy in 81% of patients with C. septicum infection, and other studies have reported similar findings [17, 35]. It is believed that ulcerative lesions of the gastrointestinal tract, especially colon carcinoma, can allow clostridial organisms to enter the bloodstream and seed an atherosclerotic focus in the aorta, resulting in the development of MAA [36]. The diagnosis of clostridial MAA requires therefore a thorough search for an occult malignancy.

Three additional cases of MAA due to C. septicum not included in the above review were also recently reported [37-39].

Clostridium paraputrificum was also reported to be associated in a single case of AMA in a patient with a myeloproliferative disorder and a necrotic carcinoma of the colon [40].

Propionibacterium acnes Infections

In addition to the patient with P. acnes MAA, described by Brook and Frazier [4], another patient was reported by Galema et al. [41].

Data recently reported by Marques da Silva et al. [42] sheds light about the potential role of Propionibacterium species as well as other anaerobic bacteria in the etiology of aortic aneurysms. The authors evaluated 53 samples from aneurysm walls that were collected from 49 patients during reconstructive surgery. The tissue specimens were sectioned and cultured under anaerobic conditions. Anaerobic cultivation yielded bacteria in 14 of the 53 samples (26.4%). All bacteria were gram-positive cocci or rods from nine genera and 12 species. Five cultures (35%) were mixed, containing two bacterial species. Mixed aerobic and anaerobic species were found in four samples (28.5%). Anaerobic bacteria were recovered from 10 of 14 positive cultures (71%). Among the anaerobes found were P. acnes (5 instances), and Propionibacterium granulosum, Actinomyces viscosus, Actinomyces naeslundii, and Eggerthella lenta (1 each). In further investigation Marques da Silva et al. [43] examined 10 aortic aneurysms for the presence of bacterial DNA using polymerase chain reaction (PCR) targeting the 16S ribosomal RNA (rRNA) gene, followed by cloning and sequencing. Sequences of P. acnes were identified in five samples and Prevotella melaninogenica were detected in one sample.

The authors concluded that the presence of bacteria in aortic aneurysms did not necessarily imply a causal relationship in aneurysm initiation and development, and some of these bacteria might have been secondary colonizers of a previously damaged vessel. However, their presence demonstrates the ability of anaerobic bacteria to reach the aortic aneurysms and participate in some instances in the mycotic process.


ANTIMICROBIAL MANAGEMENT OF MYCOTIC ANEURISM DUE TO ANAEROBIC BACTERIA

Management of MAA is one of the most challenging clinical problems. Successful resolution of MAA depends on early diagnosis, prolonged antibiotic therapy, and timely surgery. Management options of MAA include antibiotic therapy alone or in combination with surgical or endovascular therapy. No data is available regarding the effects of medical therapy alone for aneurysm infected by anaerobic bacteria. Therefore this section addresses the antimicrobial choice of agents to be used with or without surgery. Surgical treatment seems to be needed to achieve optimal results based on the review of C. septicum MAA by Takano et al. [15].

The initial therapy, which is generally empirical should cover the most likely infecting organisms. Antimicrobial effective against anaerobic bacteria should be administered empirically whenever their presence is suspected or proven. The final choice of antimicrobial agents should be based on isolation of specific organisms, aerobes as well as anaerobes from the blood or infected site and antimicrobial susceptibility testing done. Parenteral antimicrobial therapy for four to six weeks is recommended for the treatment of a MAA [44]. A longer treatment is considered when parameters of inflammation such as C-reactive protein, erythrocyte sedimentation rate, and white cell count do not return to normal.

The susceptibility of anaerobic bacteria to antimicrobial agents has become less predictable and resistance to several antimicrobial agents by B. fragilis group and other anaerobic Gram-negative bacilli has increased over the past decade [3, 45]. It is therefore important to perform susceptibility testing to the isolates recovered from patients with MAA.

The parenteral antimicrobials generally effective against anaerobic bacteria are clindamycin, metronidazole, chloramphenicol, cefoxitin, a combination of penicillin (i.e., ticarcillin, ampicillin) plus a beta-lactamase inhibitor (i.e., clavulanate, sulbactam), tigecycline, moxifloxacin, and the carbapenems (i.e. imipenem, meropenem). Aminoglycosides or a quinolones generally is added to clindamycin, metronidazole and, occasionally, cefoxitin to provide coverage for enteric bacteria, and to a carbapenem to cover for Pseudomonas [3, 45]. Penicillin is added to metronidazole to cover for microaerophilic streptococci, Actinomyces spp. and Propionibacterium spp. Penicillin is added to clindamycin to supplement its coverage against Peptostreptococcus spp. and other Gram-positive anaerobic organisms.

Antimicrobial agents that generally provide coverage for methicillin-susceptible S. aureus as well as for anaerobic bacteria include cefoxitin, clindamycin, carbapenem, tigecycline, and combinations of penicillin (e.g., ticarcillin) and a beta-lactamase-resistant penicillin. A glycopeptide (e.g., vancomycin), daptomycin, tigecycline, linezolid, and quinupristin/dalfopristin should be administered in cases in which methicillin-resistant S. aureus is present or suspected.


CONCLUSIONS

Anaerobic Gram-negative bacilli (mostly B. fragilis group), Clostridium spp. (mostly C. septicum), and Propionibacterium spp. (mostly P. acnes) are the predominant anaerobes isolated from MAA. Because anaerobic Gram-negative bacilli have increased their resistance to penicillins and other antimicrobials in recent years, complete identification and antimicrobial susceptibility testing are essential for the management of infections caused by anaerobic bacteria. The mainstay of treatment of MAA involving anaerobes includes the use of antibiotic therapy effective these organisms.


REFERENCES
1. Brook I. Anaerobic infections in childrenMicrobes InfectYear: 2002412718012467770
2. Lassmann B,Gustafson DR,Wood CM,Rosenblatt JE. Reemergence of Anaerobic BacteremiaClin Infec DisYear: 20074489590017342637
3. Boyanova L,Kolarov R,Mitov I. Antimicrobial resistance and the management of anaerobic infectionsExpert Rev Anti Infect TherYear: 2007568570117678430
4. Brook I,Frazier EH. Aerobic and anaerobic microbiology of mycotic aortic aneurysmClin Infect DisYear: 19992892892910825076
5. Sheehan JP. Bacteroides aortitis and aneurysm formation following arteriographyJ InfectYear: 1983715356689027
6. Reddy DJ,Lee RE,Oh HK. Suprarenal mycotic aortic aneurysm: surgical management and follow-upJ Vasc SurgYear: 19863917203754907
7. Suddleson EA,Katz SG,Kohl RD. Mycotic suprarenal aortic aneurysmAnn Vasc SurgYear: 19871426312973799
8. Taylor LM Jr,Deitz DM,McConnell DB,Porter JM. Treatment of infected abdominal aneurysms by extraanatomic bypass, aneurysm excision, and drainageAm J SurgYear: 198815565583369620
9. Jewkes AJ,Black J. Infection of an abdominal aortic aneurysm from an appendix abscessJ Cardiovasc Surg (Torino)Year: 1989308702
10. Reddy DJ,Shepard AD,Evans JR,Wright DJ,Smith RF,Ernst CB. Management of infected aortoiliac aneurysmsArch SurgYear: 199112687381854247
11. Hsu RB,Tsay YG,Wang SS,Chu SH. Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteriesJ Vasc SurgYear: 2002367465012368720
12. Matsuyama K,Matsumoto M,Sugita T,Nishizawa J,Kawanishi Y,Uehara K. Acute type B aortic dissection complicated with a mycotic aortic arch aneurysmJpn J Thorac Cardiovasc SurgYear: 200351545714621021
13. Tsuji Y,Okita Y,Niwaya K,et al. Allograft replacement of common iliac artery mycotic aneurysm caused by Bacteroides fragilis vertebral spondylitis-a case reportVasc Endovascular SurgYear: 200337441414671700
14. Beland MD,Soares GM,Dubel GJ,Forte MP,Murphy TP. Endovascular repair of a thoracic aorta mycotic pseudoaneurysm in a patient with history of Bacteroides fragilis sepsis and leprosyJ Vasc Interv RadiolYear: 20051629830015713936
15. Takano H,Taniguchi K,Kuki S,Nakamura T,Miyagawa S,Masai T. Mycotic aneurysm of the infrarenal abdominal aorta infected by Clostridium septicum: a case report of surgical management and review of the literatureJ Vasc SurgYear: 2003388475114560242
16. Kaufman JL,Fereshetian A,Chang B,Shah DM,Leather RP. Septicemia presenting with endoaneurysmal gas: CT demonstrationAJR Am J RoentgenolYear: 19881512872883260720
17. Murphy DP,Glazier DB,Krause TJ. Mycotic aneurysm of the thoracic aorta caused by Clostridium septicumAnn Thorac SurgYear: 199662183518378957398
18. Bridges RA,McTamaney JP,Barnes RW. Recognition and management of ruptured infected aneurysm of the abdominal aortaVasc SurgYear: 198115360366
19. Semel L,Aikman WO,Parker FB,Marvasti MA. Nontraumatic clostridial myonecrosis and mycotic aneurysm formationN Y State J MedYear: 1984841951966585705
20. Narula A,Lake SP,Baker AR,Greenwood RK. Mycotic aneurysm of the popliteal artery following right hemicolectomyPostgrad Med JYear: 1988646386393249713
21. Asplund MW,Molinaro A. Infected solitary iliac artery aneurysmJ Vasc SurgYear: 1990122192202381031
22. Brahan RB,Kahler RC. Clostridium septicum as a cause of pericarditis and mycotic aneurysmJ Clin MicrobiolYear: 199028237723782229369
23. Hurley L,Howe K. Mycotic aortic aneurysm infected by Clostridium septicum-a case historyAngiologyYear: 1991425855891863018
24. Christensen J,Bistrup C. Case report: emphysematous pyelonephritis caused by Clostridium septicum and complicated by a mycotic aneurysmBr J RadiolYear: 1993668428438220960
25. Messa CA III,Kulkarni M,Arous E. Double clostridial mycotic aneurysms of the aortaCardiovasc SurgYear: 199953687692
26. Sailors DM,Eidt JF,Gagne PJ,Barnes RW,Barone GW,McFarland DR. Primary Clostridium septicum aortitis: a rare cause of necrotizing suprarenal aortic infection. A case report and review of the literature.J Vasc SurgYear: 1996237147188627911
27. Montoya FJ,Weinstein-Moreno LF,Johnson CC. Mycotic thoracic aneurysm due to Clostridium septicum and occult adenocarcinoma of the cecumClin Infect DisYear: 1997247859142770
28. Johnson FE. Infected aortic aneurysmAm J SurgYear: 199917826810587181
29. Morrison RC Jr,DiMuzio PJ,Kahn M,Carabasi RA III,Bailey W,Edie RN. Clostridial mycotic aneurysm of the thoracoabdominal aorta-a case reportVasc SurgYear: 20013530331011586456
30. Al Bahrani BJ,Thomas DJ,Moylan EJ. What's causing that gas?Med J AustYear: 200117465211480689
31. Munshi IA,Rhee SW,Pane T,Granowitz E. Clostridium septicum mycotic aortic aneurysmAm J SurgYear: 2002184545512135720
32. Momont SL,Overholt EL. Aortitis due to metastatic gas gangreneWis Med JYear: 19898828302618068
33. Monsen T,Palmgren H,Arnerlov C,Billheden J. Aortic dissection due to Clostridium septicum infectionEur J Vasc Endovasc SurgYear: 1997135175189166278
34. Kornbluth AA,Danzig JB,Bernstein LH. Clostridium septicum infection and associated malignancy. Report of 2 cases and review of the literatureMedicine (Baltimore)Year: 19896830372642585
35. Alpern RJ,Dowell VR Jr. Clostridium septicum infections and malignancyJAMAYear: 19692093853885819436
36. Jendrzejewski JW,Jones SR,Newcombe RL,Gilbert DN. Nontraumatic clostridial myonecrosisAm J MedYear: 197865542546717421
37. Liechti ME,Schöb O,Kacl GM,Caduff B. Clostridium septicum aortitis in a patient with colon carcinomaEur J Clin Microbiol Infect DisYear: 20032263263414513404
38. Davies M,Byrne J,Harvey JS. Clostridial infection of the abdominal aortaJ Am Coll SurgYear: 200319733112892819
39. Mohamed HK,Elliott BM,Brothers TE,Robison JG. Suprarenal Clostridium septicum aortitis with rupture and simultaneous colon cancerAnn Vasc SurgYear: 20062082582916773491
40. Babenco GO,Joffe N,Tischler AS,Kasdon E. Gas-forming clostridial mycotic aneurysm of the abdominal aortaA case report. AngiologyYear: 197627602609
41. Galema L,Overbosch EH,Schrander-van der Meer AM,Brom HL,Roggeveen C,van Dorp WT. Mycotic aneurysm after aortic bifurcation prosthesisNeth J MedYear: 1996481051088935752
42. Marques da Silva R,Lingaas P,Geiran O,Tronstad L,Olsen I. Multiple bacteria in aortic aneurysmsJ Vasc SurgYear: 2003381384138914681645
43. Marques da Silva R,Caugant DA,Eribe ER. Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysisJ Vasc SurgYear: 2006441055106017098542
44. Soravia-Dunand VA,Loo VG,Salit IE. Aortitis due to salmonella: report of 10 cases and comprehensive review of the literatureClin Infect DisYear: 19992986210589904
45. Brook I. Treatment of anaerobic infectionExpert Rev Anti Infect TherYear: 20075991100618039083

Article Categories:
  • Article

Keywords: Keywords Anaerobic bacteria, mycotic aneurysm, aorta, Bacteroides fragilis, Clostridium spp., Propionibacterium acnes..

Previous Document:  Management of asymptomatic severe aortic stenosis.
Next Document:  Cardiac resynchronization therapy in children.